ities to preference shareholders - 15,504
Financial lease liabilities 445 498
Other non-current liabilities 903 45
1,348 17,085
Current liabilities
Trade payables 674 963
Payables to related parties 1,857 266
Social security and other taxes 186 153
Other current liabilities 4,291 1,433
7,008 2,815
Total liabilities 8,356 19,900
Total equity and liabilities 60,616 18,218
AMSTERDAM MOLECULAR THERAPEUTICS HOLDING N.V.
Consolidated cash flow statement
(In Euro x 1,000)
Period ended
30 June 30 June
2007 2006
Cash flow from operating
activities
Result before corporate income
tax (8,640) (3,153)
Adjustments for:
- Depreciation 134 118
- Share based payment expenses 1,543 79
- Gain on derecognition financial
lease (53) -
- Re-purchase of EMT sales rights - 1,736
- Gain on deconsolidation AVP - (1,113)
- Changes in working capital 2,767 316
- Interest income/ (expense) 1,414 76
Cash generated from operations
'/>"/>
SOURCE Amsterdam Molecular Therapeutics B.V Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 Related biology technology :1.
Detect Single Nucleotide Sequence Changes with Mx4000 Molecular Beacon
Allelic Discrimination Kits2.
Genotyping Single Nucleotide Polymorphisms with Molecular Beacons3.
New Protocols for Isolating High- Molecular-Weight Genomic DNA4.
HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex
Virus DNA5.
Molecular Biology:Easy Dephosphorylation and Rapid DNA Ligation6.
Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A7.
Quantitation of GAD67 Gene Expression in Prefrontal Cortex of Schizophrenia Patients Using the iCycler iQ Detection System and Molecular Beacons, Rev A8.
Measurement of proteasome inhibition in live cells in Molecular Devices microplate fluorometers9.
Measurement of Molecular Beacons in the SpectraMax Gemini Spectrofluorometer (MaxLine Application Note #36)10.
Kodak in vivo imaging system: precise coregistration of molecular imaging with anatomical X-ray imaging in animals11.
Near Infrared Technology and Optical Agents For Molecular Imaging